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Abstract. The bioefficacy of a commercial formulation of temephos, Creek® against Aedes aegypti
larvae was studied in the laboratory. Earthen jars were filled with 10 L tap water each. One g of
temephos (Creek®) sand granule formulation was added into each earthen jar as recommended
by the manufacturer. The final test concentration of Creek® was 1 mg a.i./L. One earthen jar was
filled with 10 L tap water and served as a test control (untreated). Thirty late 3rd or early 4th instar
of lab-bred Ae. aegypti larvae were added into each earthen jar. Mortality of the larvae was recorded
after 24 hours and percent mortality was calculated. Test was repeated every week. The results
showed that complete larval mortality was achieved after 24 hours. The residual effect lasted 15
weeks (105 days), indicating that Creek® is effective at the dosage recommended by the
manufacturer which is 1 mg a.i./L.
Dengue fever (DF) and dengue haemorrhagic
fever (DHF) are considered the most
important and disseminated vector-borne
disease of public health importance in
tropical, subtropical and temperate regions
of the world (Gubler et al., 1998). Millions of
people are infected by DF and DHF annually
(Jacobs, 2000). Aedes aegypti and Aedes
albopictus play a crucial role in the
transmission of these infections (Rebecca,
1987; Lam, 1993; Lee & Inder, 1993; Nogueira
et al., 1999).
Malaysia has suffered DF and DHF since
the first major national DF and DHF
outbreak which occurred in 1973 during
which 969 cases and a case fatality ratio of
5.6/100 were reported by Ministry of Health
(Lee, 1994). Currently, an effective dengue
vaccine is not available and the only method
of controlling or preventing DF and DHF is
to combat the vector mosquitoes. Dengue
control is still heavily dependent on the use
of chemical insecticides. Thus, insecticide
resistance represents a threat for effective
vector control. The use of chemical agents
is one of the most important methods of
controlling vectors of medical importance.
Larviciding is the first step in chemical
mosquito control, since the mosquitoes are
killed at the breeding site, prior to dispersing
and infesting a community. Since early 1970,
WHO has recommended temephos (0,0,0’0’-
t e t r a m e t h y l - 0 , 0 ’ - t h i o d i p h e n y l e n e
phosphorothiorate) for the control of Aedes
mosquitoes (WHO, 1985) and it has been
used extensively in the past 30 years for the
control of Ae. aegypti and Ae. albopictus in
Malaysia.
Temephos is an organophosphorus (OP)
compound with very low mammalian
toxicity. The LD50 of temephos on rat is about
8600 mg/kg and is not harmful to humans
when used at operational dosages (Laws et
al, 1967). Temephos has been used for the
control of mosquito larvae (Ae. aegypti,
Culex spp and Anopheles spp) in drinking
water since the early 1970s. It has been found
useful in the control of dengue and dengue
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haemorrhagic fever, malaria and filariasis
(WHO, 1991).
The objective of this study is to evaluate
the bioefficacy of a commercial formulation
of temephos, Creek® against Ae. aegypti
larvae in the laboratory.
As this was a small scale laboratory
bioassay, prior to a bigger scale study, only
2 earthen jars were used for the study.
Earthen jar with the opening of 35 cm in
diameter, base diameter of 28 cm and 15 cm
in height was used. The 2 earthen jars were
filled with 10 L tap water each. One g of
temephos (Creek®) sand granule formulation
was added into each earthen jar as
recommended by the manufacturer. This is
equivalent to a final total release dosage of
1 mg active ingredient per liter (1 mg a.i./L).
Another earthen jar was filled with 10 L tap
water and served as a control (untreated).
All the earthen jars were placed in the
laboratory and kept covered to prevent any
Aedes adults in the vicinity from ovipositing
in the earthen jars. Lab-bred Ae. aegypti
larvae (F970 – F975) which was colonized
in the Medical Entomology Unit, Institute for
Medical Research for the past 30 years was
used in this study. Thirty late 3rd or early 4th
instar  Ae. aegypti larvae were added into
each earthen jar. Mortality of the larvae was
recorded after 24 hours and percent
mortality was calculated. Test was repeated
every week.
The results obtained from this study
showed complete larval mortality was
achieved after 24 hours. The residual effect
lasted 15 weeks (105 days), indicating
that Creek® is effective at the dosage
recommended by the manufacturer which is
1 mg a.i./L.
This was similar to a study by Lee &
Winita (1993). Their study found that earthen
jars treated with 1 mg/L of temephos
(Abate®) were effective in causing complete
larval mortality of Ae. albopictus up to 91
days post-treatment.
According to WHO (1999), 1% temephos
sand granules (Abate®) are applied to
containers using a calibrated plastic spoon
to administer a dosage of 1 ppm (ad 1 mg
a.i./L). This dosage has been found to be
effective for 8 to 12 weeks, especially in
porous earthen jars, under normal water use
patterns.
Zairi (2003, cited by WHO, 2003)
reported that in the laboratory, temephos
formulation at 0.11 g/L was effective against
Ae. aegypti and Ae. albopictus released in
earthenware and glass jars with and without
replenishment of water, causing more than
90% larval mortality throughout 11 weeks
experimental period. He also reported that
in the trial against natural mosquito
population in household containers, 100 %
of larval reduction was recorded up to 65
days in all the jars.
Mulla et al. (2004) tested efficacy of
temephos sand granules (1%) and temephos
zeolite granules (1%) at operational rate of
5g / 50L (= 1 mg a.i./L) against Ae. aegypti in
glazed clay water storage jars (200 L) with
replenishment of water, were equal in
efficacy yielding almost 100% control for
more than 6 months. Thavara et al. (2004)
reported that a single application of
temephos zeolite granules at 1 mg a.i./L can
provide highly satisfactory control of Ae.
aegypti larvae in water storage containers
for period of at least 3 months in field under
normal water use practices.
Thavara et al. (2005) tested the efficacy
of temephos 1% GR at 1 and 10 g per 200 L
water in jars (0.05 and 0.5 mg a.i./L). Their
results showed that even at 1 g / 200 L water,
which is 1/20 of the recommended dosage
used in the control program, the level of
control was about 100% for up to 5 months
(20 weeks) or longer.
Beside using temephos to control
dengue vectors, temephos also provided
significant mortality of immature stages
of anopheline species in different types of
breeding habitats tested (i.e., roadside
ditches, rivers and river bed pools, and
ponds) (Shililu, 2001; Awad & Shimaila,
2003; Parvez & Al-Wahaibi, 2003). Kerdpibule
et al. (1984) also reported Abate® 1% sand
granules can also be used against species
that breed in natural water collection, such
as Mansonia and Culex.
In conclusion, the effectiveness and
residual activity of temephos Creek® 1.0G is
comparable to temephos Abate® 1.1G, if the
proper dosage is used.
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